Dagens Industri SV

Röd öppning på börsen – Yubico rekylerar upp

Stockholmsbörsen ska avsluta ännu en turbulent vecka. I fredagens inledande handel sjunker indexen. Astra Zeneca stiger efter en studieframgång, och Yubico studsar upp efter gårdagens vinstvarningsras.

Mar 27, 2026 &03052727202631; 08:05 UTC www.di.se Trending 2/5

Read original on www.di.se ↗

→

Neutral impact

Sentiment score: -15/100

Moderate impact Short-term (days)

WHAT THIS MEANS

Stockholm exchange opens lower on Friday amid broader market turbulence (S&P 500 -1.74%, VIX +0.73%). Yubico rebounds sharply after yesterday's profit warning crash, while AstraZeneca gains on positive study results.

AI CONFIDENCE

45% Moderate

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

FTSE MIB (Italy)

FTSEMIB.MIIndex

Expected to decline

Stockholm exchange opening lower in line with broader European weakness; S&P 500 down 1.74% overnight sets negative tone

↑

YUBICO

YUBICOStock

Expected to rise

Rebound/bounce after yesterday's profit warning crash — technical recovery, not new catalyst; already priced in as oversold bounce

↑

AZN.L

AZN.LStock

Expected to rise

Positive study results provide genuine catalyst; isolated strength in weak market

↑

^VIX

^VIXIndex

Expected to rise

Fear gauge elevated at 27.64 (+0.73%); reflects ongoing market turbulence and risk-off sentiment

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Market structure is bearish (broad indices down, VIX elevated). Yubico bounce is oversold rebound — avoid chasing. AstraZeneca is the only genuine positive catalyst but isolated. Wait for stabilization or clearer directional catalyst before initiating new positions. [PRICED_IN] [MOVE:0.8%]

KEY SIGNALS

S&P 500 -1.74% overnight — negative spillover to European marketsVIX +0.73% — elevated fear, risk-off positioningYubico bounce is technical recovery from crash, not new bullish catalystAstraZeneca isolated strength on study successFriday open weakness suggests continuation of turbulent week

SECTORS INVOLVED

Healthcare (AstraZeneca positive study)Technology/Cybersecurity (Yubico bounce)Broad Market (risk-off environment)

Analysis generated on Mar 27, 2026 at 08:10 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Dagens Industri. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Röd öppning på börsen – Yubico rekylerar upp

RELATED INTELLIGENCE